INS and Hypoglycemia: In addition, as previously discussed, TIR data from 2 icodec phase 3studies at the time of the switch from once-daily basal insulin to icodec showed thatsuch switches did not lead to a loss of glycemic control or more hypoglycemia when aloading dose was administered (122,123).